This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.


Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


2gqn

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:2gqn.jpg|left|200px]]
+
{{Seed}}
 +
[[Image:2gqn.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_2gqn| PDB=2gqn | SCENE= }}
{{STRUCTURE_2gqn| PDB=2gqn | SCENE= }}
-
'''Cystathionine Beta-Lyase (CBL) from Escherichia Coli in complex with N-Hydrazinocarbonylmethyl-2-Nitro-Benzamide'''
+
===Cystathionine Beta-Lyase (CBL) from Escherichia Coli in complex with N-Hydrazinocarbonylmethyl-2-Nitro-Benzamide===
-
==Overview==
+
<!--
-
The biosynthesis of methionine is an attractive antibiotic target given its importance in protein and DNA metabolism and its absence in mammals. We have performed a high-throughput screen of the methionine biosynthesis enzyme cystathionine beta-lyase (CBL) against a library of 50 000 small molecules and have identified several compounds that inhibit CBL enzyme activity in vitro. These hit molecules were of two classes: those that blocked CBL activity with mixed steady-state inhibition and those that covalently interacted with the enzyme at the active site pyridoxal phosphate cofactor with slow-binding inhibition kinetics. We determined the crystal structure of one of the slow-binding inhibitors in complex with CBL and used this structure as a guide in the synthesis of a small, focused library of analogues, some of which had improved enzyme inhibition properties. These studies provide the first lead molecules for antimicrobial agents that target cystathionine beta-lyase in methionine biosynthesis.
+
The line below this paragraph, {{ABSTRACT_PUBMED_17300162}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 17300162 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_17300162}}
==About this Structure==
==About this Structure==
Line 27: Line 31:
[[Category: Plp cofactor covalently bount to blp inhibitor]]
[[Category: Plp cofactor covalently bount to blp inhibitor]]
[[Category: Protein-inhibitor complex]]
[[Category: Protein-inhibitor complex]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May 4 05:24:41 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 03:45:11 2008''

Revision as of 00:45, 28 July 2008

Template:STRUCTURE 2gqn

Cystathionine Beta-Lyase (CBL) from Escherichia Coli in complex with N-Hydrazinocarbonylmethyl-2-Nitro-Benzamide

Template:ABSTRACT PUBMED 17300162

About this Structure

2GQN is a Single protein structure of sequence from Escherichia coli. Full crystallographic information is available from OCA.

Reference

Inhibitors of bacterial cystathionine beta-lyase: leads for new antimicrobial agents and probes of enzyme structure and function., Ejim LJ, Blanchard JE, Koteva KP, Sumerfield R, Elowe NH, Chechetto JD, Brown ED, Junop MS, Wright GD, J Med Chem. 2007 Feb 22;50(4):755-64. PMID:17300162

Page seeded by OCA on Mon Jul 28 03:45:11 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools